These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34996412)

  • 1. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
    Lau-Min KS; Varughese LA; Nelson MN; Cambareri C; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
    BMC Cancer; 2022 Jan; 22(1):47. PubMed ID: 34996412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing
    Varughese LA; Bhupathiraju M; Hoffecker G; Terek S; Harr M; Hakonarson H; Cambareri C; Marini J; Landgraf J; Chen J; Kanter G; Lau-Min KS; Massa RC; Damjanov N; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
    Front Oncol; 2022; 12():859846. PubMed ID: 35865463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists.
    Glewis S; Lingaratnam S; Krishnasamy M; H Martin J; Tie J; Alexander M; Michael M
    J Oncol Pharm Pract; 2024 Jan; 30(1):30-37. PubMed ID: 37021580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of preemptive pharmacogenetic testing in colorectal cancer patients within a community oncology setting.
    Luczak TS; Schillo PJ; Renier CM; Waring SC; Friday BB
    J Oncol Pharm Pract; 2022 Jun; 28(4):842-849. PubMed ID: 33853470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation.
    Varughese LA; Lau-Min KS; Cambareri C; Damjanov N; Massa R; Reddy N; Oyer R; Teitelbaum U; Tuteja S
    Pharmacotherapy; 2020 Nov; 40(11):1108-1129. PubMed ID: 32985005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
    Reizine N; Vokes EE; Liu P; Truong TM; Nanda R; Fleming GF; Catenacci DVT; Pearson AT; Parsad S; Danahey K; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
    Ther Adv Med Oncol; 2020; 12():1758835920974118. PubMed ID: 33414846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative approach to assess the opinion of physicians about the challenges and prospects of pharmacogenomic testing implementation in clinical practice in Greece.
    Koufaki MI; Patrinos GP; Vasileiou KZ
    Hum Genomics; 2024 Jul; 18(1):82. PubMed ID: 39030587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework.
    van der Wouden CH; Paasman E; Teichert M; Crone MR; Guchelaar HJ; Swen JJ
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32192029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
    Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
    Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic.
    Cicali EJ; Eddy E; Gong Y; Elchynski AL; Pena Del Aguila K; Basha T; Daily KC; Dickson L; Fischer S; Hastings-Monari E; Jones D; Ramnaraign BH; DeRemer DL; George TJ; Cooper-DeHoff RM
    Clin Transl Sci; 2024 Jul; 17(7):e13890. PubMed ID: 39046302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review.
    Aref HAT; Makowsky MJ; Kung JY; Guirguis LM
    J Am Pharm Assoc (2003); 2023; 63(2):459-476.e6. PubMed ID: 36371398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providers' Use of Pharmacogenetic Testing to Inform Antidepressant Prescribing: Results of Qualitative Interviews.
    Vest BM; Wray LO; Thase ME; Brady LA; Chapman SR; Oslin DW
    Psychiatr Serv; 2023 Dec; 74(12):1270-1276. PubMed ID: 37528698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
    Glewis S; Krishnasamy M; Lingaratnam S; Harris S; Underhill C; Georgiou C; Warren M; Campbell R; IJzerman M; Fagery M; Campbell I; Martin JH; Tie J; Alexander M; Michael M
    Clin Transl Sci; 2023 Dec; 16(12):2700-2708. PubMed ID: 37877594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.
    Vest BM; Wray LO; Brady LA; Thase ME; Beehler GP; Chapman SR; Hull LE; Oslin DW
    BMC Psychiatry; 2020 Oct; 20(1):518. PubMed ID: 33115428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice.
    Wiss FM; Jakober D; Lampert ML; Allemann SS
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
    Tuteja S; Salloum RG; Elchynski AL; Smith DM; Rowe E; Blake KV; Limdi NA; Aquilante CL; Bates J; Beitelshees AL; Cipriani A; Duong BQ; Empey PE; Formea CM; Hicks JK; Mroz P; Oslin D; Pasternak AL; Petry N; Ramsey LB; Schlichte A; Swain SM; Ward KM; Wiisanen K; Skaar TC; Van Driest SL; Cavallari LH; Bishop JR;
    Clin Transl Sci; 2022 Feb; 15(2):371-383. PubMed ID: 34562070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice.
    Kaur G; Nwabufo CK
    Pharmacogenet Genomics; 2024 Sep; 34(7):236-245. PubMed ID: 38917295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients.
    Lteif C; Eddy E; Terrell J; Cavallari LH; Malaty J; Duarte JD
    Clin Transl Sci; 2024 Jan; 17(1):e13692. PubMed ID: 38013396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.